Top Analyst Downgrades and Stocks to Sell: Sprint, Caterpillar, ViroPharma and More

24/7 Wall St.

Stocks have rallied and investors are looking for ideas on which stocks to buy and which stocks to sell. 24/7 Wall St. reviews many fresh research calls each morning to find great ideas from value stocks to growth stocks to dividend stocks, and we have broken out the negative analyst calls here. These are this Wednesday's top analyst downgrades and cautious research notes seen from Wall Street this morning.

Caterpillar Inc. (CAT) was downgraded to Neutral from Outperform at Baird.

Clorox Co. (CLX) was downgraded to Underweight from Equal Weight at Barclays.

GAMCO Investors Inc. (GBL) was downgraded to Underperform from Buy, based on price appreciation and valuation, at BofA/Merrill Lynch.

ALSO READ: The World's Largest Automakers

Intuit Inc. (INTU) was downgraded to Underweight from Equal Weight at Morgan Stanley.

NRG Energy Inc. (NRG) was downgraded to Neutral from the Conviction Buy List with a $28 price target (versus $27.92 close) by Goldman Sachs.

Procter & Gamble Co. (PG) was downgraded to Equal Weight from Overweight at Barclays.

Sprint Corp. (NYSE: S) was started with an Underperform rating and $5.50 price target (versus $6.39 close) at Credit Suisse.

Symantec Corp. (SYMC) was given a cautious Neutral rating in new coverage at Nomura.

ViroPharma Inc. (VPHM) was downgraded to Underperform from Neutral with a $34 price target (versus $40.78 close), after takeover speculation, at BofA/Merrill Lynch.

Related Articles

View Comments